Peritoneal Cavity Cancer clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
open to eligible people ages 18 years and up
A Study of Emi-Le in Participants with Solid Tumors
at UC Irvine UCLA UCSF
Our lead scientists for Peritoneal Cavity Cancer research studies include Laura Huppert.
Last updated: